A guidance note for trainees
The introduction of new curricula is often complex as legacy programmes are phased out and the programmes using the new curricula are introduced. We know that trainees will need to make critical decisions about their future careers and we will share this important information as soon as we can.
The Internal Medicine Stage one (IMS1) curriculum launched for new trainees in August 2019. Unlike CMT, this is a three-year programme with the first ‘graduates’ exiting in 2022 from the full programme. The curricula and programmes for Group 1 specialties will become active in 2022 and Group 2 specialties will become active and recruit in 2021.
In 2021 there will be the possibility to recruit to legacy Group 1 programmes at a time when there will be no output from IMS1. Recruitment to some Group 1 specialties (GUM, Palliative Care Medicine and Neurology) together with some Cardiology posts, may need to be treated differently.
We are currently developing guidance to cover the following circumstances:
- Routes by which previous trainees who left CMT but did not enter a higher specialty training programme can be supported back in to training
- Whether recruitment to legacy programmes should occur in 2021 for some or all specialties in Group 1. Under the existing guidelines if such recruitment was to occur trainees would have to move to the new curricula when these are approved by the GMC. Such programmes would be only open to those who attained an Outcome 6 (or equivalent) from CMT.
We will carefully consider the number of posts that may be available for recruitment in 2021 and the specialties of these posts. This will depend on the number of trainees who have previously completed CMT and who wish to return to training and the number of posts required for Internal Medicine Year 3 for those in the IMS1 programme.
A set of Frequently Asked Questions (FAQs) will also be available soon.